Arctic Bioscience — Proxy Solicitation & Information Statement 2026

May 13, 2026

Arctic Bioscience - Notice of Annual General Meeting on 27 May 2026

Arctic Bioscience - Notice of Annual General Meeting on 27 May 2026

Arctic Bioscience AS' Annual General Meeting will be held Wednesday 27 May 2026

at 11:00 (CET), as a digital meeting.

Shareholders are encouraged to cast their votes in advance of the General

Meeting or grant the Chair of the Board a proxy, with or without voting

instructions.

The deadline for registration of attendance, advance votes, proxy or

instructions is 22 May 2026 at 16:00 (CET). For attendance at the live event,

please follow the instructions in the notice.

For further information, see the attached Notice of the Annual General Meeting,

which can also be accessed from the company's website (https://arctic

-bioscience.com/investors/general-meetings/).

Proposed board changes:

It is proposed to make changes to the board positions as follows:

· Tore A. F. Tønseth is elected as new chairperson

· Harald Nordal is elected as board member

The board will thus consist of the following members:

· Tore A. F. Tønseth (chairperson) (new election)

· Jan Endre Vartdal (reelection)

· Harald Nordal (new election)

· Marita Holstad (reelection)

· Olav Sindre Kriken (reelection)

This information is subject to the disclosure requirements pursuant to section 5

-12 of the Norwegian Securities Trading Act.

For more information, please contact:

Christer L. Valderhaug

CEO

Phone: +47 920 84 601

E-mail: christer@arctic-bioscience.com

Jone R. Slinning

CFO

Mobile: +47 948 75 469

E-mail: jone@arctic-bioscience.com

About Arctic Bioscience

Arctic Bioscience is a biotech company developing and commercializing

pharmaceutical and nutraceutical products based on unique bioactive marine

compounds.

The company is developing HRO350 - a novel oral drug candidate. HRO350 is being

developed for treatment of patients with mild-to-moderate psoriasis. This is a

large patient group in need of new effective medicines with beneficial safety

profile.

Nutraceuticals from Arctic Bioscience are sold globally as bulk ingredients as

well as finished goods under the ROMEGA® brand.

Arctic Bioscience is led by a highly skilled team of talents with diverse and

highly relevant background.